[1]
|
Zhu, K.F., Wang, Y.M., Zhu, J.Z., et al. (2016) National Prevalence of Coronary Heart Disease and Its Relationship with Human Development Index: A Systematic Review. European Journal of Preventive Cardiology, 23, 530-543.
https://doi.org/10.1177/2047487315587402
|
[2]
|
Hansson, G.K. (2005) Inflammation, Atherosclerosis, and Coro-nary Artery Disease. New England Journal of Medicine, 352, 1685-1695. https://doi.org/10.1056/NEJMra043430
|
[3]
|
Carlevaro, M.F., Cermelli, S., Cancedda, R., et al. (2000) Vascular Endothelial Growth Factor (VEGF) in Cartilage Neovascularization and Chondrocyte Differentiation: Auto-Paracrine Role during Endochondral Bone Formation. Journal of Cell Science, 113, 59-69. https://doi.org/10.1242/jcs.113.1.59
|
[4]
|
Melincovici, C.S., Boşca, A.B., Şuşman, S., et al. (2018) Vascular Endo-thelial Growth Factor (VEGF)—Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morpholo-gy and Embryology, 59, 455-467.
|
[5]
|
Claesson-Welsh, L. and Welsh, M. (2013) VEGFA and Tumour Angiogenesis. Journal of Internal Medicine, 273, 114-127. https://doi.org/10.1111/joim.12019
|
[6]
|
Itatani, Y., Kawada, K., Yamamoto, T., et al. (2018) Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. In-ternational Journal of Molecular Sciences, 19, Article No. 1232.
https://doi.org/10.3390/ijms19041232
|
[7]
|
Garcia, R., Bouleti, C., Sirol, M., et al. (2019) VEGF-A Plasma Levels Are Associated with Microvascular Obstruction in Patients with ST-Segment Elevation Myocardial Infarction. Interna-tional Journal of Cardiology, 291, 19-24.
https://doi.org/10.1016/j.ijcard.2019.02.067
|
[8]
|
Zhao, Y., Kong, L., Pei, Z., et al. (2021) m7G Methyltransferase METTL1 Promotes Post-Ischemic Angiogenesis via Promoting VEGFA mRNA Translation. Frontiers in Cell and De-velopmental Biology, 9, Article ID: 642080.
https://doi.org/10.3389/fcell.2021.642080
|
[9]
|
Tang, H., Zhang, S., Huang, C., et al. (2021) MiR-448-5p/VEGFA Axis Protects Cardiomyocytes from Hypoxia Through Regulating the FAS/FAS-L Signaling Pathway. International Heart Journal, 62, 647-657.
https://doi.org/10.1536/ihj.20-600
|
[10]
|
Zou, J., Fei, Q., Xiao, H., et al. (2019) VEGF-A Promotes Angiogenesis after Acute Myocardial Infarction through Increasing ROS Production and Enhancing ER Stress-Mediated Autophagy. Journal of Cellular Physiology, 234, 17690- 17703. https://doi.org/10.1002/jcp.28395
|
[11]
|
Liu, T., Sun, F., Cui, J., et al. (2020) Morroniside Enhances Angiogenesis and Improves Cardiac Function Following Acute Myocardial Infarc-tion in Rats. European Journal of Pharmacology, 872, Article ID: 172954.
https://doi.org/10.1016/j.ejphar.2020.172954
|
[12]
|
Zou, J., Wang, N., Liu, M., et al. (2018) Nucleolin Mediated Pro-Angiogenic Role of Hydroxysafflor Yellow A in Ischaemic Cardiac Dysfunction: Post-Transcriptional Regulation of VEGF-A and MMP-9. Journal of Cellular and Molecular Medicine, 22, 2692-2705. https://doi.org/10.1111/jcmm.13552
|
[13]
|
Wang, H., Chen, L., Wang, S., et al. (2021) Tetrandrine Promotes Angi-ogenesis via Transcriptional Regulation of VEGF-A. Vascular Pharmacology, 141, Article ID: 106920. https://doi.org/10.1016/j.vph.2021.106920
|
[14]
|
Lv, Y.X., Zhong, S., Tang, H., et al. (2018) VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation. Cellular Physiology and Biochemistry, 48, 433-449.
https://doi.org/10.1159/000491775
|
[15]
|
Kivelä, R., Bry, M., Robciuc, M.R., et al. (2014) VEGF-B-Induced Vas-cular Growth Leads to Metabolic Reprogramming and Ischemia Resistance in the Heart. EMBO Molecular Medicine, 6, 307-321.
https://doi.org/10.1002/emmm.201303147
|
[16]
|
Bulysheva, A.A., Burcus, N., Lundberg, C.G., et al. (2018) VEGF-B Electrotransfer Mediated Gene Therapy Induces Cardiomyogenesis in a Rat Model of Cardiac Ischemia. Bioe-lectrochemistry, 124, 105-111.
https://doi.org/10.1016/j.bioelechem.2018.07.007
|
[17]
|
Korpela, H., Hätinen, O.P., Nieminen, T., et al. (2021) Ad-enoviral VEGF-B186R127S Gene Transfer Induces Angiogenesis and Improves Perfusion in Ischemic Heart. iScience, 24, Article ID: 103533.
https://doi.org/10.1016/j.isci.2021.103533
|
[18]
|
Lähteenvuo, J.E., Lähteenvuo, M.T., Kivelä, A., et al. (2009) Vas-cular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endo-thelial Growth Factor Receptor-1- and Neuropilin Receptor-1-Dependent Mechanisms. Circulation, 119, 845-856.
https://doi.org/10.1161/CIRCULATIONAHA.108.816454
|
[19]
|
Nurro, J., Halonen, P.J., Kuivanen, A., et al. (2016) AdVEGF-B186 and AdVEGF-DΔNΔC Induce Angiogenesis and Increase Perfusion in Porcine Myocardium. Heart, 102, 1716-1720. https://doi.org/10.1136/heartjnl-2016-309373
|
[20]
|
Suh, S.H., Choe, K., Hong, S.P., et al. (2019) Gut Microbiota Regulates Lacteal Integrity by Inducing VEGF-C in Intestinal Villus Macrophages. EMBO Re-ports, 20, e46927. https://doi.org/10.15252/embr.201846927
|
[21]
|
Wada, H., Suzuki, M., Matsuda, M., et al. (2018) VEGF-C and Mortality in Patients with Suspected or Known Coronary Artery Disease. Journal of the American Heart Association, 7, e010355.
https://doi.org/10.1161/JAHA.118.010355
|
[22]
|
Chen, X.G., Lv, Y.X., Zhao, D., et al. (2016) Vascular Endothelial Growth Factor-C Protects Heart from Ischemia/ Reperfusion Injury by Inhibiting Cardiomyocyte Apoptosis. Molecular and Cellular Biochemistry, 413, 9-23.
https://doi.org/10.1007/s11010-015-2622-9
|
[23]
|
Zhang, H.F., Wang, Y.L., Tan, Y.Z., et al. (2019) Enhancement of Cardiac Lymphangiogenesis by Transplantation of CD34(+)VEGFR-3(+) Endothelial Progenitor Cells and Sustained Release of VEGF-C. Basic Research in Cardiology, 114, Article No. 43. https://doi.org/10.1007/s00395-019-0752-z
|
[24]
|
Yue, Y., Huang, S., Wang, L., et al. (2020) M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis after Reperfusion Injury. Circulation Journal, 84, 626-635. https://doi.org/10.1253/circj.CJ-19-0959
|
[25]
|
Fox, K.A.A., Metra, M., Morais, J., et al. (2020) The Myth of “Stable” Coronary Artery Disease. Nature Reviews Cardiology, 17, 9-21. https://doi.org/10.1038/s41569-019-0233-y
|
[26]
|
Zhao, W., Zhao, T., Chen, Y., et al. (2015) Angiotensin 1-7 Pro-motes Cardiac Angiogenesis Following Infarction. Current Vascular Pharmacology, 13, 37-42. https://doi.org/10.2174/15701611113119990006
|
[27]
|
(2018) Corrigendum to: Adenoviral Intramyocardial VEGF-DΔNΔC Gene Transfer Increases Myocardial Perfusion Reserve in Refractory Angina Patients: A Phase I/IIa Study with 1-Year Follow-Up. European Heart Journal, 39, Article No. 1652. https://doi.org/10.1093/eurheartj/ehx576
|
[28]
|
Saito, Y. (2021) The Role of the PlGF/Flt-1 Signaling Pathway in the Cardiorenal Connection. The Journal of Molecular and Cellular Cardiology, 151, 106-112. https://doi.org/10.1016/j.yjmcc.2020.10.001
|
[29]
|
Dewerchin, M. and Carmeliet, P. (2012) PlGF: A Multitasking Cytokine with Disease-Restricted Activity. Cold Spring Harbor Perspectives in Medicine, 2, a011056. https://doi.org/10.1101/cshperspect.a011056
|
[30]
|
Zhang, Y., Cao, C., Xin, J., et al. (2018) Treatment with Placental Growth Factor Attenuates Myocardial Ischemia/Reperfusion Injury. PLOS ONE, 13, e0202772. https://doi.org/10.1371/journal.pone.0202772
|
[31]
|
Takeda, Y., Uemura, S., Iwama, H., et al. (2009) Treatment with Recombinant Placental Growth Factor (PlGF) Enhances both Angiogenesis and Arteriogenesis and Improves Survival after Myocardial Infarction. Circulation Journal, 73, 1674-1682. https://doi.org/10.1253/circj.CJ-08-1067
|
[32]
|
Luttun, A., Tjwa, M., Moons, L., et al. (2002) Revascularization of Ischemic Tissues by PlGF Treatment, and Inhibition of Tumor Angiogenesis, Arthritis and Atherosclerosis by Anti-Flt1. Nature Medicine, 8, 831-840.
https://doi.org/10.1038/nm731
|
[33]
|
Li, B., Sharpe, E.E., Maupin, A.B., et al. (2006) VEGF and PlGF Promote Adult Vasculogenesis by Enhancing EPC Recruitment and Vessel Formation at the Site of Tumor Neovascularization. The FASEB Journal, 20, 1495-1497.
https://doi.org/10.1096/fj.05-5137fje
|
[34]
|
Iwama, H., Uemura, S., Naya, N., et al. (2006) Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients with Acute Myocardial Infarction. Journal of the American College of Cardiology, 47, 1559-1567. https://doi.org/10.1016/j.jacc.2005.11.064
|
[35]
|
Matsumoto, T., Uemura, S., Takeda, Y., et al. (2013) An Elevated Ratio of Placental Growth Factor to Soluble FMS-Like Tyrosine Kinase-1 Predicts Adverse Outcomes in Patients with Stable Coronary Artery Disease. Internal Medicine, 52, 1019-1027. https://doi.org/10.2169/internalmedicine.52.9073
|
[36]
|
Iwasaki, H., Kawamoto, A., Tjwa, M., et al. (2011) PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors. PLOS ONE, 6, e24872.
https://doi.org/10.1371/journal.pone.0024872
|